Tag: David Gutmann April 15, 2024 Epilepsy drug prevents brain tumors in mice with NF1Study lays groundwork for clinical trial aimed at preventing brain tumors in children with NF1.News Release May 20, 2022 Gutmann elected to Association of American PhysiciansRecognized for advancing understanding of neurofibromatosis.National Leaders May 19, 2022 Epilepsy drug stops nervous system tumor growth in miceHyperactive neurons drive tumor growth in NF1 cancer predisposition syndrome.News Release December 10, 2021 Asthma may reduce risk of brain tumors — but how?Mouse study IDs immune cells as link, points to potential therapeutic approaches.News Release May 26, 2021 Brain tumors caused by normal neuron activity in mice predisposed to such tumorsLight triggers formation, feeds growth of optic nerve tumors.News Release November 9, 2020 Gutmann receives Neuro-oncology Scientific AwardRecognized for study of pediatric brain tumors.National Leaders September 16, 2020 Gutmann receives award from neurological associationHonored for work on role of immune system in brain tumors.National Leaders May 4, 2020 Gutmann receives Advocate of Hope awardHonored for dedication to finding causes, treatments for common genetic disease.National Leaders May 1, 2020 New targets for childhood brain tumors identifiedNeurons, immune cells work together to promote tumor growth in neurofibromatosis type 1.News Release October 1, 2019 Gutmann wins prestigious neuro-oncology prizeHonored for work on pediatric brain tumors.National Leaders May 29, 2019 Immune cells determine how fast certain tumors growStudy suggests new approaches to treating NF1 brain tumors.News Release January 7, 2019 Mice sleeping fitfully provide clues to insomniaGenetically engineered mice mimic common sleep problems.News Release Posts navigation 1 2 Next ›
